Latest News

NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug Regimens with Alternative Mechanism of Action

SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced new real-world data on treatment patterns for patients with advanced colorectal cancer (CRC) during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical Oncology (ASCO). The Symposium, held at the Moscone West Building in San Francisco, CA from January 23-25, provides evidence-based teaching met

Source link

Related posts

Food Allergies Tied to MS Relapses


Study Finds Diabetes, Heart Failure a Dangerous Duo


The interplay between inflammation, immunity and commensal microflora in glaucomatous neurodegeneration


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy